Innogenetics announces definitive closure of GENimmune
03 Jun 2008 -
Innogenetics announced the final phase of its restructuring plan for the pharma division of GENimmune. In accordance with the collective labor agreement signed on May 8 with its social partners, the remaining 5 labor contracts will shortly be terminated.